Prescription Drug Market Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a… read more

Prescription Drug Market Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a hearing on prescription drug cost increases. The CEOs explained the rationale behind the increases and other factors affecting market competition. Martin Shkreli, who received widespread attention when his former Turing Pharmaceuticals company obtained the license for the drug Daraprim and raised its price by over 5,000 percent, declined to answer questions and exercised his FIfth Amendment right against self-incrimination. The FDA officials described the backlog of generic drug applications and what they are doing to expedite the review process. close

People in this video

More People

Hosting Organization

More information about

Prescription Drug Market

11,491 Views
Program ID:
404183-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Feb 4, 2016
Last Aired:
Feb 10, 2016

Airing Details

  • Feb 04, 2016 | 9:02am EST | C-SPAN.org
  • Feb 04, 2016 | 3:47pm EST | C-SPAN 1
  • Feb 04, 2016 | 4:10pm EST | C-SPAN RADIO
  • Feb 04, 2016 | 6:05pm EST | C-SPAN 1
  • Feb 04, 2016 | 8:00pm EST | C-SPAN 2
  • Feb 05, 2016 | 2:43am EST | C-SPAN 2
  • Feb 05, 2016 | 5:37am EST | C-SPAN 2
  • Feb 05, 2016 | 11:41am EST | C-SPAN 2
  • Feb 10, 2016 | 7:06am EST | C-SPAN 3
Purchase a DVD or Download

Prescription Drug Market

  • DVD
    Price:
    $29.95
  • MP4 video - Low
    Price:
    Free
  • MP4 video - Standard
    Price:
    $6.99
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video

View all clips from this video